New MUSE™ System Patient Experience Data To Be Presented During Digestive Disease Week® (DDW) 2016

OMER, Israel, May 16, 2016 — Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced the presentation of new MUSE™ System patient experience data at the upcoming Digestive Disease Week® (DDW), being held in San Diego, Calif., from May 21-24, 2016.

“We look forward to sharing the clinical findings on patient outcomes following procedures conducted with the MUSE system,” stated Chris Rowland, CEO of Medigus. “MUSE addresses unmet need in long-term GERD care and has the potential to help millions of people suffering from the troublesome symptoms of acid reflux, who fall within the widening treatment gap between drug therapy and invasive surgical procedures.”

The MUSE system allows physicians to perform transoral fundoplication for the treatment of GERD (gastroesophageal reflux disease), often referred to as acid reflux. GERD is among the most common chronic conditions in the U.S. In fact, it impacts up to 60% of American adults and GERD-related hospitalizations increased more than 200% in recent years.

MUSE Poster Presentation – Tuesday, May 24, from 12noon-2pm PT
Ultrasonic Assisted Endoscopic Full Thickness Fundoplasty, Single Center Experience in the First 14 U.S. Patients, during Poster Session # 2433544
Ali Lankarani, MD1, Anand Patel, MD1, John Petersen, DO1, Scott Cooper MD1, Jose Nieto, DO1
1 Borland Groover Clinic, Advanced Therapeutic Endoscopy Center, Jacksonville, FL, USA

DDW attendees can visit the Medigus booth (#1019) to learn more about the MUSE system, or visit www.medigus.com.